nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Tetany—Cisplatin—esophageal cancer	0.0432	0.0547	CcSEcCtD
Flumazenil—Shivering—Capecitabine—esophageal cancer	0.0279	0.0353	CcSEcCtD
Flumazenil—Panic attack—Capecitabine—esophageal cancer	0.0279	0.0353	CcSEcCtD
Flumazenil—Depressed mood—Capecitabine—esophageal cancer	0.0232	0.0294	CcSEcCtD
Flumazenil—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.0159	0.02	CcSEcCtD
Flumazenil—Hearing impaired—Cisplatin—esophageal cancer	0.0148	0.0187	CcSEcCtD
Flumazenil—Pain—Carboplatin—esophageal cancer	0.0147	0.0185	CcSEcCtD
Flumazenil—Tongue disorder—Capecitabine—esophageal cancer	0.0143	0.0181	CcSEcCtD
Flumazenil—Hiccups—Cisplatin—esophageal cancer	0.0141	0.0178	CcSEcCtD
Flumazenil—Rigors—Capecitabine—esophageal cancer	0.0127	0.0161	CcSEcCtD
Flumazenil—Injection site pain—Capecitabine—esophageal cancer	0.0127	0.0161	CcSEcCtD
Flumazenil—Dysphonia—Capecitabine—esophageal cancer	0.0126	0.016	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.0115	0.0145	CcSEcCtD
Flumazenil—Deafness—Cisplatin—esophageal cancer	0.0114	0.0145	CcSEcCtD
Flumazenil—Nasal congestion—Cisplatin—esophageal cancer	0.0112	0.0142	CcSEcCtD
Flumazenil—Hearing impaired—Capecitabine—esophageal cancer	0.0109	0.0138	CcSEcCtD
Flumazenil—Hiccups—Capecitabine—esophageal cancer	0.0104	0.0131	CcSEcCtD
Flumazenil—Stupor—Methotrexate—esophageal cancer	0.0104	0.0131	CcSEcCtD
Flumazenil—Injection site reaction—Capecitabine—esophageal cancer	0.0103	0.0131	CcSEcCtD
Flumazenil—Depressed level of consciousness—Capecitabine—esophageal cancer	0.01	0.0127	CcSEcCtD
Flumazenil—Abnormal vision—Capecitabine—esophageal cancer	0.00906	0.0115	CcSEcCtD
Flumazenil—Speech disorder—Methotrexate—esophageal cancer	0.00899	0.0114	CcSEcCtD
Flumazenil—Thrombophlebitis—Capecitabine—esophageal cancer	0.00871	0.011	CcSEcCtD
Flumazenil—Sweating increased—Cisplatin—esophageal cancer	0.00861	0.0109	CcSEcCtD
Flumazenil—Deafness—Capecitabine—esophageal cancer	0.00843	0.0107	CcSEcCtD
Flumazenil—Hot flush—Capecitabine—esophageal cancer	0.00806	0.0102	CcSEcCtD
Flumazenil—Menopausal symptoms—Capecitabine—esophageal cancer	0.00799	0.0101	CcSEcCtD
Flumazenil—Diplopia—Capecitabine—esophageal cancer	0.00754	0.00954	CcSEcCtD
Flumazenil—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00747	0.00944	CcSEcCtD
Flumazenil—Bradycardia—Cisplatin—esophageal cancer	0.00721	0.00911	CcSEcCtD
Flumazenil—Mood swings—Capecitabine—esophageal cancer	0.00715	0.00903	CcSEcCtD
Flumazenil—Ataxia—Capecitabine—esophageal cancer	0.00709	0.00897	CcSEcCtD
Flumazenil—Visual impairment—Cisplatin—esophageal cancer	0.00682	0.00862	CcSEcCtD
Flumazenil—Tinnitus—Cisplatin—esophageal cancer	0.0066	0.00834	CcSEcCtD
Flumazenil—Flushing—Cisplatin—esophageal cancer	0.00657	0.00831	CcSEcCtD
Flumazenil—Thrombophlebitis—Methotrexate—esophageal cancer	0.00649	0.0082	CcSEcCtD
Flumazenil—Sweating increased—Capecitabine—esophageal cancer	0.00635	0.00803	CcSEcCtD
Flumazenil—Arrhythmia—Cisplatin—esophageal cancer	0.00632	0.008	CcSEcCtD
Flumazenil—Erythema—Cisplatin—esophageal cancer	0.00616	0.00779	CcSEcCtD
Flumazenil—Vision blurred—Cisplatin—esophageal cancer	0.00581	0.00734	CcSEcCtD
Flumazenil—Tremor—Cisplatin—esophageal cancer	0.00577	0.0073	CcSEcCtD
Flumazenil—Ill-defined disorder—Cisplatin—esophageal cancer	0.00572	0.00723	CcSEcCtD
Flumazenil—Malaise—Cisplatin—esophageal cancer	0.00556	0.00703	CcSEcCtD
Flumazenil—Mood swings—Methotrexate—esophageal cancer	0.00532	0.00673	CcSEcCtD
Flumazenil—Bradycardia—Capecitabine—esophageal cancer	0.00531	0.00672	CcSEcCtD
Flumazenil—Ataxia—Methotrexate—esophageal cancer	0.00528	0.00668	CcSEcCtD
Flumazenil—Anxiety—Cisplatin—esophageal cancer	0.00523	0.00661	CcSEcCtD
Flumazenil—Hypoaesthesia—Capecitabine—esophageal cancer	0.00519	0.00656	CcSEcCtD
Flumazenil—Discomfort—Cisplatin—esophageal cancer	0.00518	0.00655	CcSEcCtD
Flumazenil—Visual impairment—Capecitabine—esophageal cancer	0.00503	0.00636	CcSEcCtD
Flumazenil—Tachycardia—Cisplatin—esophageal cancer	0.00491	0.00621	CcSEcCtD
Flumazenil—Tinnitus—Capecitabine—esophageal cancer	0.00486	0.00615	CcSEcCtD
Flumazenil—Hyperhidrosis—Cisplatin—esophageal cancer	0.00486	0.00615	CcSEcCtD
Flumazenil—Flushing—Capecitabine—esophageal cancer	0.00484	0.00612	CcSEcCtD
Flumazenil—Hypotension—Cisplatin—esophageal cancer	0.0047	0.00594	CcSEcCtD
Flumazenil—Chills—Capecitabine—esophageal cancer	0.00468	0.00592	CcSEcCtD
Flumazenil—Arrhythmia—Capecitabine—esophageal cancer	0.00466	0.00589	CcSEcCtD
Flumazenil—Erythema—Capecitabine—esophageal cancer	0.00454	0.00574	CcSEcCtD
Flumazenil—Paraesthesia—Cisplatin—esophageal cancer	0.00452	0.00571	CcSEcCtD
Flumazenil—Dyspnoea—Cisplatin—esophageal cancer	0.00448	0.00567	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—esophageal cancer	0.00433	0.00547	CcSEcCtD
Flumazenil—Pain—Cisplatin—esophageal cancer	0.0043	0.00544	CcSEcCtD
Flumazenil—Vision blurred—Capecitabine—esophageal cancer	0.00428	0.00541	CcSEcCtD
Flumazenil—Tremor—Capecitabine—esophageal cancer	0.00426	0.00538	CcSEcCtD
Flumazenil—Ill-defined disorder—Capecitabine—esophageal cancer	0.00421	0.00533	CcSEcCtD
Flumazenil—GABRA6—Orphan transporters—SLC10A2—esophageal cancer	0.00415	0.0199	CbGpPWpGaD
Flumazenil—Sweating—Methotrexate—esophageal cancer	0.00415	0.00524	CcSEcCtD
Flumazenil—Feeling abnormal—Cisplatin—esophageal cancer	0.00414	0.00524	CcSEcCtD
Flumazenil—GABRA4—Orphan transporters—SLC10A2—esophageal cancer	0.0041	0.0196	CbGpPWpGaD
Flumazenil—Malaise—Capecitabine—esophageal cancer	0.0041	0.00518	CcSEcCtD
Flumazenil—Vertigo—Capecitabine—esophageal cancer	0.00408	0.00516	CcSEcCtD
Flumazenil—Palpitations—Capecitabine—esophageal cancer	0.00401	0.00508	CcSEcCtD
Flumazenil—GABRA6—GABA receptor activation—GNG7—esophageal cancer	0.00399	0.0191	CbGpPWpGaD
Flumazenil—Cough—Capecitabine—esophageal cancer	0.00396	0.00501	CcSEcCtD
Flumazenil—GABRA4—GABA receptor activation—GNG7—esophageal cancer	0.00394	0.0188	CbGpPWpGaD
Flumazenil—Hypertension—Capecitabine—esophageal cancer	0.00392	0.00496	CcSEcCtD
Flumazenil—Chest pain—Capecitabine—esophageal cancer	0.00387	0.00489	CcSEcCtD
Flumazenil—Anxiety—Capecitabine—esophageal cancer	0.00385	0.00487	CcSEcCtD
Flumazenil—Discomfort—Capecitabine—esophageal cancer	0.00382	0.00483	CcSEcCtD
Flumazenil—Dry mouth—Capecitabine—esophageal cancer	0.00378	0.00478	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—esophageal cancer	0.00374	0.00473	CcSEcCtD
Flumazenil—Confusional state—Capecitabine—esophageal cancer	0.00374	0.00473	CcSEcCtD
Flumazenil—Hypersensitivity—Cisplatin—esophageal cancer	0.00371	0.00468	CcSEcCtD
Flumazenil—GABRA5—Orphan transporters—SLC10A2—esophageal cancer	0.00364	0.0174	CbGpPWpGaD
Flumazenil—Tinnitus—Methotrexate—esophageal cancer	0.00362	0.00458	CcSEcCtD
Flumazenil—Tachycardia—Capecitabine—esophageal cancer	0.00362	0.00457	CcSEcCtD
Flumazenil—Asthenia—Cisplatin—esophageal cancer	0.00361	0.00456	CcSEcCtD
Flumazenil—Hyperhidrosis—Capecitabine—esophageal cancer	0.00358	0.00453	CcSEcCtD
Flumazenil—GABRA3—Orphan transporters—SLC10A2—esophageal cancer	0.00358	0.0171	CbGpPWpGaD
Flumazenil—GABRA2—Orphan transporters—SLC10A2—esophageal cancer	0.00352	0.0168	CbGpPWpGaD
Flumazenil—GABRA5—GABA receptor activation—GNG7—esophageal cancer	0.0035	0.0167	CbGpPWpGaD
Flumazenil—GABRB3—Orphan transporters—SLC10A2—esophageal cancer	0.00349	0.0167	CbGpPWpGaD
Flumazenil—Chills—Methotrexate—esophageal cancer	0.00349	0.00441	CcSEcCtD
Flumazenil—Hypotension—Capecitabine—esophageal cancer	0.00346	0.00438	CcSEcCtD
Flumazenil—GABRA3—GABA receptor activation—GNG7—esophageal cancer	0.00344	0.0164	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—SLC10A2—esophageal cancer	0.00343	0.0164	CbGpPWpGaD
Flumazenil—Erythema—Methotrexate—esophageal cancer	0.00338	0.00428	CcSEcCtD
Flumazenil—GABRA2—GABA receptor activation—GNG7—esophageal cancer	0.00338	0.0162	CbGpPWpGaD
Flumazenil—GABRB3—GABA receptor activation—GNG7—esophageal cancer	0.00336	0.0161	CbGpPWpGaD
Flumazenil—Insomnia—Capecitabine—esophageal cancer	0.00335	0.00424	CcSEcCtD
Flumazenil—Paraesthesia—Capecitabine—esophageal cancer	0.00333	0.00421	CcSEcCtD
Flumazenil—Dyspnoea—Capecitabine—esophageal cancer	0.0033	0.00418	CcSEcCtD
Flumazenil—GABRG2—GABA receptor activation—GNG7—esophageal cancer	0.0033	0.0158	CbGpPWpGaD
Flumazenil—Vomiting—Cisplatin—esophageal cancer	0.0032	0.00404	CcSEcCtD
Flumazenil—Fatigue—Capecitabine—esophageal cancer	0.0032	0.00404	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—esophageal cancer	0.00319	0.00403	CcSEcCtD
Flumazenil—Rash—Cisplatin—esophageal cancer	0.00317	0.00401	CcSEcCtD
Flumazenil—Pain—Capecitabine—esophageal cancer	0.00317	0.00401	CcSEcCtD
Flumazenil—Dermatitis—Cisplatin—esophageal cancer	0.00317	0.00401	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—esophageal cancer	0.00314	0.00397	CcSEcCtD
Flumazenil—Feeling abnormal—Capecitabine—esophageal cancer	0.00305	0.00386	CcSEcCtD
Flumazenil—Malaise—Methotrexate—esophageal cancer	0.00305	0.00386	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—esophageal cancer	0.00304	0.00384	CcSEcCtD
Flumazenil—GABRA1—Orphan transporters—SLC10A2—esophageal cancer	0.003	0.0143	CbGpPWpGaD
Flumazenil—Nausea—Cisplatin—esophageal cancer	0.00299	0.00378	CcSEcCtD
Flumazenil—Cough—Methotrexate—esophageal cancer	0.00295	0.00373	CcSEcCtD
Flumazenil—Urticaria—Capecitabine—esophageal cancer	0.00294	0.00372	CcSEcCtD
Flumazenil—GABRA1—GABA receptor activation—GNG7—esophageal cancer	0.00288	0.0138	CbGpPWpGaD
Flumazenil—Chest pain—Methotrexate—esophageal cancer	0.00288	0.00364	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—esophageal cancer	0.00284	0.0036	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—esophageal cancer	0.00278	0.00352	CcSEcCtD
Flumazenil—GABRA6—Ion channel transport—ATP1B2—esophageal cancer	0.00274	0.0131	CbGpPWpGaD
Flumazenil—Hypersensitivity—Capecitabine—esophageal cancer	0.00273	0.00345	CcSEcCtD
Flumazenil—GABRA4—Ion channel transport—ATP1B2—esophageal cancer	0.0027	0.0129	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CRTC1—esophageal cancer	0.00269	0.0129	CbGpPWpGaD
Flumazenil—Hyperhidrosis—Methotrexate—esophageal cancer	0.00267	0.00337	CcSEcCtD
Flumazenil—Asthenia—Capecitabine—esophageal cancer	0.00266	0.00336	CcSEcCtD
Flumazenil—Pruritus—Capecitabine—esophageal cancer	0.00262	0.00332	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—esophageal cancer	0.00258	0.00326	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—esophageal cancer	0.0025	0.00316	CcSEcCtD
Flumazenil—Paraesthesia—Methotrexate—esophageal cancer	0.00248	0.00313	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—esophageal cancer	0.00246	0.00311	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—esophageal cancer	0.00245	0.0031	CcSEcCtD
Flumazenil—Dizziness—Capecitabine—esophageal cancer	0.00245	0.0031	CcSEcCtD
Flumazenil—GABRA5—Ion channel transport—ATP1B2—esophageal cancer	0.0024	0.0115	CbGpPWpGaD
Flumazenil—Fatigue—Methotrexate—esophageal cancer	0.00238	0.00301	CcSEcCtD
Flumazenil—GABRA6—Ion channel transport—ATP4A—esophageal cancer	0.00237	0.0114	CbGpPWpGaD
Flumazenil—Pain—Methotrexate—esophageal cancer	0.00236	0.00298	CcSEcCtD
Flumazenil—GABRA3—Ion channel transport—ATP1B2—esophageal cancer	0.00236	0.0113	CbGpPWpGaD
Flumazenil—Vomiting—Capecitabine—esophageal cancer	0.00236	0.00298	CcSEcCtD
Flumazenil—GABRA4—Ion channel transport—ATP4A—esophageal cancer	0.00234	0.0112	CbGpPWpGaD
Flumazenil—Rash—Capecitabine—esophageal cancer	0.00234	0.00296	CcSEcCtD
Flumazenil—Dermatitis—Capecitabine—esophageal cancer	0.00234	0.00295	CcSEcCtD
Flumazenil—Headache—Capecitabine—esophageal cancer	0.00232	0.00294	CcSEcCtD
Flumazenil—GABRA2—Ion channel transport—ATP1B2—esophageal cancer	0.00232	0.0111	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—ATP1B2—esophageal cancer	0.0023	0.011	CbGpPWpGaD
Flumazenil—Feeling abnormal—Methotrexate—esophageal cancer	0.00227	0.00288	CcSEcCtD
Flumazenil—GABRG2—Ion channel transport—ATP1B2—esophageal cancer	0.00226	0.0108	CbGpPWpGaD
Flumazenil—Nausea—Capecitabine—esophageal cancer	0.0022	0.00278	CcSEcCtD
Flumazenil—Urticaria—Methotrexate—esophageal cancer	0.00219	0.00277	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.00217	0.0104	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—ATP4A—esophageal cancer	0.00208	0.00996	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—ATP4A—esophageal cancer	0.00205	0.00978	CbGpPWpGaD
Flumazenil—Hypersensitivity—Methotrexate—esophageal cancer	0.00203	0.00257	CcSEcCtD
Flumazenil—GABRA2—Ion channel transport—ATP4A—esophageal cancer	0.00201	0.00961	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—ATP4A—esophageal cancer	0.002	0.00955	CbGpPWpGaD
Flumazenil—Asthenia—Methotrexate—esophageal cancer	0.00198	0.0025	CcSEcCtD
Flumazenil—GABRA1—Ion channel transport—ATP1B2—esophageal cancer	0.00198	0.00946	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—ATP4A—esophageal cancer	0.00196	0.00938	CbGpPWpGaD
Flumazenil—Pruritus—Methotrexate—esophageal cancer	0.00195	0.00247	CcSEcCtD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00183	0.00878	CbGpPWpGaD
Flumazenil—Dizziness—Methotrexate—esophageal cancer	0.00182	0.00231	CcSEcCtD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00181	0.00867	CbGpPWpGaD
Flumazenil—Vomiting—Methotrexate—esophageal cancer	0.00175	0.00222	CcSEcCtD
Flumazenil—Rash—Methotrexate—esophageal cancer	0.00174	0.0022	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—esophageal cancer	0.00174	0.0022	CcSEcCtD
Flumazenil—Headache—Methotrexate—esophageal cancer	0.00173	0.00219	CcSEcCtD
Flumazenil—GABRA1—Ion channel transport—ATP4A—esophageal cancer	0.00171	0.0082	CbGpPWpGaD
Flumazenil—Nausea—Methotrexate—esophageal cancer	0.00164	0.00207	CcSEcCtD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00161	0.0077	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CFL1—esophageal cancer	0.0016	0.00766	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00158	0.00756	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00155	0.00743	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00154	0.00738	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00152	0.00725	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.0014	0.00668	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00138	0.0066	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00136	0.00651	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00132	0.00634	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00129	0.00618	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00129	0.00616	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00128	0.0061	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00124	0.00595	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00121	0.00579	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00119	0.00568	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00117	0.00559	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00116	0.00555	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00114	0.00545	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00113	0.00542	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00111	0.00533	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00109	0.00523	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00109	0.0052	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00107	0.00511	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—GNG7—esophageal cancer	0.00106	0.00506	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—GNG7—esophageal cancer	0.00104	0.00499	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00101	0.00485	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.001	0.00479	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000996	0.00476	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—ALDH2—esophageal cancer	0.00099	0.00474	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—ALDH2—esophageal cancer	0.000978	0.00468	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000968	0.00463	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000953	0.00456	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000941	0.0045	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000933	0.00446	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—GNG7—esophageal cancer	0.000927	0.00443	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—GNG7—esophageal cancer	0.000911	0.00435	CbGpPWpGaD
Flumazenil—GABRA6—Orphan transporters—CREBBP—esophageal cancer	0.00091	0.00435	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000904	0.00432	CbGpPWpGaD
Flumazenil—GABRA4—Orphan transporters—CREBBP—esophageal cancer	0.000898	0.0043	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—GNG7—esophageal cancer	0.000895	0.00428	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000892	0.00427	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000889	0.00425	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—GNG7—esophageal cancer	0.000889	0.00425	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000873	0.00418	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—GNG7—esophageal cancer	0.000873	0.00418	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—ALDH2—esophageal cancer	0.000869	0.00416	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000862	0.00412	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000858	0.0041	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—ALDH2—esophageal cancer	0.000853	0.00408	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000853	0.00408	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000851	0.00407	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—ALDH2—esophageal cancer	0.000839	0.00401	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000837	0.004	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000836	0.004	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—ALDH2—esophageal cancer	0.000833	0.00398	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000826	0.00395	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000826	0.00395	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000821	0.00393	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—ALDH2—esophageal cancer	0.000818	0.00391	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000816	0.0039	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000816	0.0039	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000807	0.00386	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000802	0.00383	CbGpPWpGaD
Flumazenil—GABRA5—Orphan transporters—CREBBP—esophageal cancer	0.000798	0.00382	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000793	0.00379	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000787	0.00376	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—CREBBP—esophageal cancer	0.000784	0.00375	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000778	0.00372	CbGpPWpGaD
Flumazenil—GABRA2—Orphan transporters—CREBBP—esophageal cancer	0.00077	0.00368	CbGpPWpGaD
Flumazenil—GABRB3—Orphan transporters—CREBBP—esophageal cancer	0.000765	0.00366	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000765	0.00366	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—GNG7—esophageal cancer	0.000763	0.00365	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00076	0.00363	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000756	0.00362	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—CREBBP—esophageal cancer	0.000751	0.00359	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000746	0.00357	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000743	0.00355	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000732	0.0035	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00073	0.00349	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000725	0.00347	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000725	0.00347	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000725	0.00347	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—ALDH2—esophageal cancer	0.000715	0.00342	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000712	0.0034	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000712	0.0034	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000712	0.0034	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.0007	0.00335	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.0007	0.00335	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000695	0.00332	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000695	0.00332	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000688	0.00329	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000683	0.00326	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000683	0.00326	CbGpPWpGaD
Flumazenil—GABRA1—Orphan transporters—CREBBP—esophageal cancer	0.000657	0.00314	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000652	0.00312	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000626	0.003	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000622	0.00298	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000618	0.00296	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000597	0.00285	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000597	0.00285	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000581	0.00278	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000568	0.00272	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000561	0.00268	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000549	0.00263	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00054	0.00258	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00053	0.00254	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000527	0.00252	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000517	0.00247	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000499	0.00238	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00049	0.00234	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000481	0.0023	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000478	0.00229	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000475	0.00227	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000469	0.00224	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000452	0.00216	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00041	0.00196	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000346	0.00166	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000342	0.00164	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000332	0.00159	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000328	0.00157	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000323	0.00155	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000304	0.00145	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000298	0.00143	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000293	0.0014	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000292	0.00139	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000291	0.00139	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000286	0.00137	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000286	0.00137	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000281	0.00135	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00028	0.00134	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000274	0.00131	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00025	0.0012	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00024	0.00115	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000222	0.00106	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000219	0.00105	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000195	0.000932	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000191	0.000915	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000188	0.000899	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000187	0.000894	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000183	0.000877	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00016	0.000767	CbGpPWpGaD
